HomeTagsPoseida Therapeutics

Poseida Therapeutics

Biotechnology

Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma

News Desk - March 14, 2024

Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...

Healthcare

Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy

PR Newswire - December 12, 2022

Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...